APA (7th ed.) Citation

M, G., HJ, S., PM, V., W, H., & M, S. (2008). Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. Annals of the rheumatic diseases, 67(5), 620. https://doi.org/10.1136/ard.2007.076711

Chicago Style (17th ed.) Citation

M, Gengenbacher, Sebald HJ, Villiger PM, Hofstetter W, and Seitz M. "Infliximab Inhibits Bone Resorption by Circulating Osteoclast Precursor Cells in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis." Annals of the Rheumatic Diseases 67, no. 5 (2008): 620. https://doi.org/10.1136/ard.2007.076711.

MLA (9th ed.) Citation

M, Gengenbacher, et al. "Infliximab Inhibits Bone Resorption by Circulating Osteoclast Precursor Cells in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis." Annals of the Rheumatic Diseases, vol. 67, no. 5, 2008, p. 620, https://doi.org/10.1136/ard.2007.076711.